Overview

The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This is a randomized controlled trial designed to evaluate the role of screening for and intervening on patients with high on treatment platelet reactivity undergoing lower extremity arterial endovascular interventions.
Phase:
Phase 3
Details
Lead Sponsor:
Kyle Markel
Treatments:
Ticagrelor